{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T05:06:21Z","timestamp":1786338381327,"version":"build-2736575974"},"reference-count":62,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"151","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2012,9,12]]},"abstract":"<jats:p>Lethal toxin\u2013neutralizing activity in serum after vaccination can provide cross-species predictions of survival against inhalation anthrax.<\/jats:p>","DOI":"10.1126\/scitranslmed.3004073","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T21:22:26Z","timestamp":1347484946000},"source":"Crossref","is-referenced-by-count":49,"title":["Anthrax Vaccine\u2013Induced Antibodies Provide Cross-Species Prediction of Survival to Aerosol Challenge"],"prefix":"10.1126","volume":"4","author":[{"given":"Michael P.","family":"Fay","sequence":"first","affiliation":[{"name":"Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, 6700B Rockledge Drive, Bethesda, MD 20892\u20137630, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean A.","family":"Follmann","sequence":"additional","affiliation":[{"name":"Biostatistics Research Branch, National Institute of Allergy and Infectious Diseases, 6700B Rockledge Drive, Bethesda, MD 20892\u20137630, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freyja","family":"Lynn","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, 6610 Rockledge Drive, Bethesda, MD 20892\u20136604, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jarad M.","family":"Schiffer","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory V.","family":"Stark","sequence":"additional","affiliation":[{"name":"Battelle, 505 King Avenue, Columbus, OH 43201, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kohberger","sequence":"additional","affiliation":[{"name":"Blair &amp; Co., Greenwich, CT 06830, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad P.","family":"Quinn","sequence":"additional","affiliation":[{"name":"Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA 30333, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin O.","family":"Nuzum","sequence":"additional","affiliation":[{"name":"Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, 6610 Rockledge Drive, Bethesda, MD 20892\u20136604, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","unstructured":"Food and Drug Administration Subpart H\u2014Approval of Biological Products When Human Efficacy Studies Are Not Ethical or Feasible (Food and Drug Administration Silver Spring MD 2009)."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1007-1084"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1086\/589862"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1268"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2008.04.016"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0197-2456(01)00153-2"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.24.1.67"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.3122"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/522428"},{"key":"e_1_3_2_11_2","first-page":"454","article-title":"VACCINATION against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Leeds, Leyton, Manchester, Middlesex, Oxford, Poole, Tottenham, Walthamstow, and Wembley.","volume":"2","author":"Medical Research Council","year":"1956","unstructured":"Medical Research Council, VACCINATION against whooping-cough; relation between protection in children and results of laboratory tests; a report to the Whooping-cough Immunization Committee of the Medical Research Council and to the medical officers of health for Cardiff, Leeds, Leyton, Manchester, Middlesex, Oxford, Poole, Tottenham, Walthamstow, and Wembley. Br. Med. J. 2, 454\u2013462 (1956).","journal-title":"Br. Med. J."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2129"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"L. M. Joellenbeck L. L. Zwanzinger J. S. Durch B. L. Strom The Anthrax Vaccine: Is It Safe? Does It Work? (The National Academies Press Washington DC 2002).","DOI":"10.21236\/ADA403352"},{"key":"e_1_3_2_14_2","unstructured":"Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research Anthrax Vaccines: Efficacy Testing and Surrogate Markers of Immunity Workshop ; http:\/\/www.fda.gov\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/TranscriptsMinutes\/default.htm"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.52.2.454-458.1986"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1128\/aem.55.8.2098-2100.1989"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.54.2.537-542.1986"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(94)90027-2"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/97.2.203"},{"key":"e_1_3_2_20_2","first-page":"425","article-title":"Protection of sheep against anthrax by immunization with an antigen prepared in vitro.","volume":"16","author":"Boor A. K.","year":"1955","unstructured":"Boor A. K., Tresselt H. B., Protection of sheep against anthrax by immunization with an antigen prepared in vitro. Am. J. Vet. Res. 16, 425\u2013428 (1955).","journal-title":"Am. J. Vet. Res."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/97.2.207"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.2.662-668.1992"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.58.2.303-308.1990"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00268-5"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.7.3447-3448.1998"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.69.5.2888-2893.2001"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/biot.200800213"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2003.07.004"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2672.1999.00897.x"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(01)00234-1"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(98)80112-6"},{"key":"e_1_3_2_32_2","first-page":"125","article-title":"Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys.","volume":"87","author":"Ivins B. E.","year":"1996","unstructured":"Ivins B. E., Fellows P. F., Pitt M. L., Estep J. E., Welkos S. L., Worsham P. L., Friedlander A. M., Efficacy of a standard human anthrax vaccine against Bacillus anthracis aerosol spore challenge in rhesus monkeys. Salisbury Med. Bull. 87, 125\u2013126 (1996).","journal-title":"Salisbury Med. Bull."},{"key":"e_1_3_2_33_2","first-page":"130","article-title":"Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalation anthrax.","volume":"87","author":"Pitt M. L. M.","year":"1996","unstructured":"Pitt M. L. M., Ivins B. E., Estep J. E., Farchaus J., Friedlander A. M., Comparison of the efficacy of purified protective antigen and MDPH to protect non-human primates from inhalation anthrax. Salisbury Med. Bull. 87, 130 (1996).","journal-title":"Salisbury Med. Bull."},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.73.9.5978-5987.2005"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00003-08"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020380"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2003.09.003"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2008.01.007"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.13.1532"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/bsp.2007.0066"},{"key":"e_1_3_2_41_2","unstructured":"Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research Anthrax Vaccines: Bridging Correlates of Protection in Animals to Immunogenicity in Humans ; http:\/\/www.fda.gov\/BiologicsBloodVaccines\/NewsEvents\/WorkshopsMeetingsConferences\/TranscriptsMinutes\/default.htm"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.1.245-252.1993"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.2011.02535.x"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19970915)16:17<1965::AID-SIM630>3.0.CO;2-M"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1198\/tast.2009.08210"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780110204"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.2307\/2533853"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1177\/001316446002000104"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.2307\/2529310"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.52.4.632"},{"key":"e_1_3_2_51_2","unstructured":"Human Genome Sciences Inc. Anti-Infectives Advisory Committee Briefing Document: Raxibacumab Treatment of Inhalation Anthrax BLA 125349 September 21 2009 (Food and Drug Administration Silver Spring MD 2009)."},{"key":"e_1_3_2_52_2","first-page":"919","article-title":"Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum.","volume":"11","author":"Semenova V. A.","year":"2004","unstructured":"Semenova V. A., Steward-Clark E., Stamey K. L., Taylor T. H., Schmidt D. S., Martin S. K., Marano N., Quinn C. P., Mass value assignment of total and subclass immunoglobulin G in a human standard anthrax reference serum. Clin. Diagn. Lab. Immunol. 11, 919\u2013923 (2004).","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(83)90303-4"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2010.09.001"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","unstructured":"B. Efron R. J. Tibshirani An Introduction to the Bootstrap (Chapman and Hall New York 1993).","DOI":"10.1007\/978-1-4899-4541-9"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2006.04.004"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780091208"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/26.4.404"},{"key":"e_1_3_2_59_2","unstructured":"National Research Council Guide for the Care and Use of Laboratory Animals (The National Academies Press Washington DC 2011); http:\/\/oacu.od.nih.gov\/regs\/guide\/guide.pdf"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-0420.2008.01106.x"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780080407"},{"key":"e_1_3_2_62_2","doi-asserted-by":"crossref","unstructured":"J. Pearl E. Bareinboim Transportability Across Studies: A Formal Approach (University of California Los Angeles 2012).","DOI":"10.21236\/ADA557437"},{"key":"e_1_3_2_63_2","doi-asserted-by":"crossref","unstructured":"J. Pearl Causality: Models Reasoning and Inference (Cambridge University Press Cambridge ed. 2 2009).","DOI":"10.1017\/CBO9780511803161"}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3004073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T16:58:38Z","timestamp":1705424318000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3004073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,12]]},"references-count":62,"journal-issue":{"issue":"151","published-print":{"date-parts":[[2012,9,12]]}},"alternative-id":["10.1126\/scitranslmed.3004073"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3004073","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,12]]}}}